scholarly article | Q13442814 |
P356 | DOI | 10.1253/CIRCJ.69.283 |
P698 | PubMed publication ID | 15731532 |
P2093 | author name string | Yoshihiko Seino | |
Kazuteru Funahashi | |||
Mitsuru Suwa | |||
Shinsuke Matsuki | |||
Yoshikata Nomachi | |||
P433 | issue | 3 | |
P921 | main subject | heart failure | Q181754 |
acute decompensated heart failure | Q4677930 | ||
P304 | page(s) | 283-290 | |
P577 | publication date | 2005-03-01 | |
P1433 | published in | Circulation Journal | Q1955928 |
P1476 | title | Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy | |
P478 | volume | 69 |
Q33618498 | ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha |
Q48179076 | ANP is cleared much faster than BNP in patients with congestive heart failure |
Q34643664 | Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide |
Q98944124 | Association between NPPA promoter methylation and hypertension: results from Gusu cohort and replication in an independent sample |
Q91588858 | Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease |
Q38816005 | Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells. |
Q37249880 | Atrial natriuretic peptide down-regulates neutrophil recruitment on inflamed endothelium by reducing cell deformability and resistance to detachment force |
Q36860608 | Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions |
Q47717243 | Circadian Regulation of Renal Function. |
Q49151463 | Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study. |
Q41141539 | Comparison of the Effects of Carperitide and Tolvaptan on Patients with Left Ventricular Dysfunction: A Two-Center Retrospective Study. |
Q37058407 | Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy |
Q35086479 | Designer natriuretic peptides |
Q83965872 | Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes |
Q89324590 | Effect of carperitide on in-hospital mortality of patients admitted for heart failure: propensity score analyses |
Q36664047 | Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial |
Q47893208 | Favorable effects of early tolvaptan administration in very elderly patients after repeat hospitalizations for acute decompensated heart failure |
Q92641654 | Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction |
Q35046791 | Genetic variation in the natriuretic peptide system and heart failure |
Q30469953 | Hypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organization |
Q53519480 | Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide. |
Q33653332 | Innovative Therapeutics: Designer Natriuretic Peptides |
Q37329891 | Modulation of cGMP in heart failure: a new therapeutic paradigm |
Q26827702 | Natriuretic Peptides and Cardiometabolic Health |
Q38371173 | Natriuretic Peptides as a Novel Target in Resistant Hypertension |
Q36794409 | Natriuretic peptides and therapeutic applications |
Q90182838 | Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure |
Q38202895 | Novel drug targets in clinical development for heart failure. |
Q38072635 | Novel vasodilators in heart failure |
Q38360688 | Privileged frameworks from snake venom. |
Q36054705 | Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides |
Q36140769 | Recombinant Atrial Natriuretic Peptide Prevents Aberrant Ca2+ Leakage through the Ryanodine Receptor by Suppressing Mitochondrial Reactive Oxygen Species Production Induced by Isoproterenol in Failing Cardiomyocytes |
Q37900203 | Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment |
Q37703738 | The heart as an endocrine organ. |
Q37286819 | The role of atrial natriuretic peptide to attenuate inflammation in a mouse skin wound and individually perfused rat mesenteric microvessels |
Search more.